Autophagy and cancer

Turkish Journal of Biology

Volumn 38, Issue 6, 2014, Pages 720-739

  Karakaş, Hacer Ezgi ^a   Gözüaçik, Devrim ^a  

^a SABANCI UNIVERSITY   (Turkey)

Author keywords

Autophagy; Cancer; Cell death; Chemotherapy; Metastasis; Oncogenes; Stress; Tumor; Tumor suppressors

Indexed keywords

EID: 84911372833     PISSN: 13000152     EISSN: 13036092     Source Type: Journal    
DOI: 10.3906/biy-1408-16     Document Type: Review

References (221)

1. Aita V.M., Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S., Gilliam TC, Levine B (1999). Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59-65.
2. Amaravadi R.K., Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A., Thompson CB (2007). Autophagy inhibition enhances therapy-induced apoptosis in a Mycinduced model of lymphoma. J Clin Invest 117: 326-336.
3. An C.H., Kim MS, Yoo NJ, Park SW, Lee SH (2011). Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers. Pathol Res Pract 207: 433-437.
4. Bareford M.D., Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N, Eulitt P, Hubbard N, Tye G, Burow ME et al. (2011). Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res 71: 4955-4967.
5. Beau I., Esclatine A, Codogno P (2008). Lost to translation: when autophagy targets mature ribosomes. Trends Cell Biol 18: 311-314.
6. Bellodi C., Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M., Galavotti S, Young KW, Selmi T, Yacobi R et al. (2009). Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosomepositive cells, including primary CML stem cells. J Clin Invest 119: 1109-1123.
7. Bellot G., Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM (2009). Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29: 2570-2581.
8. Bensaad K., Cheung EC, Vousden KH (2009). Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J 28: 3015-3026.
9. Berthier A., Seguin S, Sasco AJ, Bobin JY, De Laroche G, Datchary J, Saez S, Rodriguez-Lafrasse C, Tolle F, Fraichard A et al. (2010). High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer. Br J Cancer 102: 1024-1031.
10. Betin V.M., Lane JD (2009). Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J Cell Sci 122: 2554-2566.
11. Brigger D., Torbett BE, Chen J, Fey MF, Tschan MP (2013). Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation. Biochem Biophys Res Commun 438: 283-288.
12. Bucci C., Thomsen P, Nicoziani P, McCarthy J, van Deurs B (2000). Rab7: a key to lysosome biogenesis. Mol Biol Cell 11: 467-480.
13. Carew J.S., Medina EC, Esquivel JA 2nd, Mahalingam D, Swords R, Kelly K., Zhang H, Huang P, Mita AC, Mita MM et al. (2010). Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med 14: 2448-2459.
14. Carew J.S., Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton J.A., Huang P, Giles FJ, Cleveland JL (2007). Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 110: 313-322.
15. Carneiro L.A., Travassos LH (2013). The interplay between NLRs and autophagy in immunity and inflammation. Front Immunol 4: 361.
16. Chano T., Kontani K, Teramoto K, Okabe H, Ikegawa S (2002). Truncating mutations of RB1CC1 in human breast cancer. Nat Genet 31: 285-288.
17. Chittaranjan S., Bortnik S, Dragowska WH, Xu J, Abeysundara N, Leung A., Go NE, Devorkin L, Weppler S, Gelmon KA et al. (2014). Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and resistant triple negative breast cancer. Clin Cancer Res 20: 3159-3173.
18. Cho D.H., Jo YK, Kim SC, Park IJ, Kim JC (2012). Down-regulated expression of ATG5 in colorectal cancer. Anticancer Res 32: 4091-4096.
19. Choi J., Jung W, Koo JS (2013). Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Histopathology 62: 275-286.
20. Chresta C.M., Davies BR, Hickson I, Harding T, Cosulich S, Critchlow SE, Vincent JP, Ellston R, Jones D, Sini P et al. (2010). AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 70: 288-298.
21. Cliby W., Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC, Jenkins RB (1993). Human epithelial ovarian cancer allelotype. Cancer Res 53: 2393-2398.
22. Copetti T., Bertoli C, Dalla E, Demarchi F, Schneider C (2009). p65/ RelA modulates BECN1 transcription and autophagy. Mol Cell Biol 29: 2594-2608.
23. Coppola D., Helm J, Ghayouri M, Malafa MP, Wang HG (2011). Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma. Pancreas 40: 433-437.
24. Coppola D., Khalil F, Eschrich SA, Boulware D, Yeatman T, Wang HG (2008a). Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma. Cancer 113: 2665-2670.
25. Coppola D., Oliveri C, Sayegh Z, Boulware D, Takahashi Y, Pow- Sang J., Djeu JY, Wang HG (2008b). Bax-interacting factor-1 expression in prostate cancer. Clin Genitourin Cancer 6: 117- 121.
26. Corradetti M.N., Inoki K, Bardeesy N, DePinho RA, Guan KL (2004). Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz- Jeghers syndrome. Genes Dev 18: 1533-1538.
27. Crighton D., Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M., Garrone O, Crook T, Ryan KM (2006). DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-134.
28. Degenhardt K., Mathew R, Beaudoin B, Bray K, Anderson D, Chen G., Mukherjee C, Shi Y, Gelinas C, Fan Y et al. (2006). Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64.
29. Degtyarev M., De Maziere A, Orr C, Lin J, Lee BB, Tien JY, Prior WW, van Dijk S, Wu H, Gray DC et al. (2008). Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol 183: 101-116.
30. Deng Q., Wang Z, Wang L, Zhang L, Xiang X, Chong T (2013). Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma. Jpn J Clin Oncol 43: 1261-1268.
31. Ding Z.B., Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, Shi GM, Wang XY, Ke AW, Wu B et al. (2008). Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res 68: 9167-9175.
32. Dong L.W., Hou YJ, Tan YX, Tang L, Pan YF, Wang M, Wang HY (2011). Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. Autophagy 7: 1222-1229.
33. Dong M., Wan XB, Yuan ZY, Wei L, Fan XJ, Wang TT, Lv YC, Li X, Chen Z.H., Chen J et al. (2013). Low expression of Beclin 1 and elevated expression of HIF-1alpha refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Med Oncol 30: 355.
34. Eberhart K., Oral O, Gozuacik D (2013). Induction of autophagic cell death by anticancer agents. In: Hayat M, editor. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, and Infection. Amsterdam, the Netherlands: Elsevier Academic Press, pp. 179-202.
35. Egan D., Kim J, Shaw RJ, Guan KL (2011). The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 7: 643-644.
36. Elgendy M., Sheridan C, Brumatti G, Martin SJ (2011). Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 42: 23-35.
37. Eskelinen E.L., Tanaka Y, Saftig P (2003). At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 13: 137-145.
38. Fabre C., Carvalho G, Tasdemir E, Braun T, Ades L, Grosjean J, Boehrer S., Metivier D, Souquere S, Pierron G et al. (2007). NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 26: 4071-4083.
39. Fader C.M., Sanchez DG, Mestre MB, Colombo MI (2009). TI-VAMP/ VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta 1793: 1901-1916.
40. Fujii S., Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, Kinoshita T., Ueno T, Esumi H, Ochiai A (2008). Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99: 1813-1819.
41. Fujita N., Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T (2008). The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell 19: 2092- 2100.
42. Funderburk S.F., Wang QJ, Yue Z (2010). The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. Trends Cell Biol 20: 355-362.
43. Fung C., Lock R, Gao S, Salas E, Debnath J (2008). Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell 19: 797-806.
44. Futreal P.A., Soderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW (1992). Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52: 2624-2627.
45. Gandemer V., Rio AG, de Tayrac M, Sibut V, Mottier S, Ly Sunnaram B, Henry C, Monnier A, Berthou C, Le Gall E et al. (2007). Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia. BMC Genomics 8: 385.
46. Geoerger B., Kerr K, Tang CB, Fung KM, Powell B, Sutton LN, Phillips PC, Janss AJ (2001). Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/ medulloblastoma models as single agent and in combination chemotherapy. Cancer Res 61: 1527-1532.
47. Gewirtz DA (2009). Autophagy, senescence and tumor dormancy in cancer therapy. Autophagy 5: 1232-1234.
48. Gozuacik D., Bialik S, Raveh T, Mitou G, Shohat G, Sabanay H, Mizushima N., Yoshimori T, Kimchi A (2008). DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ 15: 1875-1886.
49. Gozuacik D., Kimchi A (2004). Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906.
50. Gozuacik D., Kimchi A (2007). Autophagy and cell death. Curr Top Dev Biol 78: 217-245.
51. Grunwald V., DeGraffenried L, Russel D, Friedrichs WE, Ray RB, Hidalgo M (2002). Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Cancer Res 62: 6141-6145.
52. Guertin D.A., Sabatini DM (2007). Defining the role of mTOR in cancer. Cancer Cell 12: 9-22.
53. Guo J.Y., Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM, Karantza V et al. (2011). Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25: 460-470.
54. Guo J.Y., Karsli-Uzunbas G, Mathew R, Aisner SC, Kamphorst JJ, Strohecker A.M., Chen G, Price S, Lu W, Teng X et al. (2013a). Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 27: 1447-1461.
55. Guo J.Y., Xia B, White E (2013b). Autophagy-mediated tumor promotion. Cell 155: 1216-1219.
56. Hershko A., Ciechanover A (1998). The ubiquitin system. Annu Rev Biochem 67: 425-479.
57. Hosokawa N., Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S., Natsume T, Takehana K, Yamada N et al. (2009). Nutrient-dependent mTORC1 association with the ULK1- Atg13-FIP200 complex required for autophagy. Mol Biol Cell 20: 1981-1991.
58. Hu N., Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ, Han XY, Goldstein AM, Emmert-Buck MR, Buetow KH et al. (2005). Genomewide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res 65: 2542-2546.
59. Huang J.J., Li HR, Huang Y, Jiang WQ, Xu RH, Huang HQ, Lv Y, Xia Z.J., Zhu XF, Lin TY et al. (2010). Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Autophagy 6: 777-783.
60. Huang X., Bai HM, Chen L, Li B, Lu YC (2010). Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci 17: 1515- 1519.
61. Huijbers A., Plantinga TS, Joosten LA, Aben KK, Gudmundsson J, den Heijer M, Kiemeney LA, Netea MG, Hermus AR, Netea- Maier RT (2012). The effect of the ATG16L1 Thr300Ala polymorphism on susceptibility and outcome of patients with epithelial cell-derived thyroid carcinoma. Endocr Relat Cancer 19: L15-18.
62. Huo Y., Cai H, Teplova I, Bowman-Colin C, Chen G, Price S, Barnard N, Ganesan S, Karantza V, White E et al. (2013). Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov 3: 894-907.
63. Inbal B., Bialik S, Sabanay I, Shani G, Kimchi A (2002). DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 157: 455-468.
64. Inoki K., Li Y, Xu T, Guan KL (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17: 1829-1834.
65. Ionov Y., Nowak N, Perucho M, Markowitz S, Cowell JK (2004). Manipulation of nonsense mediated decay identifies gene mutations in colon cancer cells with microsatellite instability. Oncogene 23: 639-645.
66. Iqbal J., Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H, Klinkebiel D., Christman JK, Patel K, Cao K et al. (2009). Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 23: 1139-1151.
67. Itakura E., Kishi C, Inoue K, Mizushima N (2008). Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 19: 5360-5372.
68. Itakura E., Kishi-Itakura C, Mizushima N (2012). The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151: 1256-1269.
69. Itakura E., Mizushima N (2010). Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy 6: 764-776.
70. Jahreiss L., Menzies FM, Rubinsztein DC (2008). The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic 9: 574-587.
71. Jiang L., Duan BS, Huang JX, Jiao X, Zhu XW, Sheng HH, Gao HJ, Yu H (2014). Association of the expression of unc-51-Like kinase 1 with lymph node metastasis and survival in patients with esophageal squamous cell carcinoma. Int J Clin Exp Med 7: 1349-1354.
72. Jiang S., Li Y, Zhu YH, Wu XQ, Tang J, Li Z, Feng GK, Deng R, Li DD, Luo RZ et al. (2011). Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Sci 102: 1568-1575.
73. Jiang Z.F., Shao LJ, Wang WM, Yan XB, Liu RY (2012). Decreased expression of Beclin-1 and LC3 in human lung cancer. Mol Biol Rep 39: 259-267.
74. Jo Y.K., Kim SC, Park IJ, Park SJ, Jin DH, Hong SW, Cho DH, Kim JC (2012). Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis. PLoS One 7: e52705.
75. Jung C.H., Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH (2009). ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 20: 1992- 2003.
76. Kang M.R., Kim MS, Oh JE, Kim YR, Song SY, Kim SS, Ahn CH, Yoo N.J., Lee SH (2009). Frameshift mutations of autophagyrelated genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol 217: 702-706.
77. Kanzawa T., Kondo Y, Ito H, Kondo S, Germano I (2003). Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 63: 2103-2108.
78. Karantza-Wadsworth V., Patel S, Kravchuk O, Chen G, Mathew R, Jin S, White E (2007). Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21: 1621-1635.
79. Karin M (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
80. Kauppi M., Simonsen A, Bremnes B, Vieira A, Callaghan J, Stenmark H, Olkkonen VM (2002). The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking. J Cell Sci 115: 899-911.
81. Kaushik S., Cuervo AM (2012). Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 22: 407-417.
82. Kim D.H., Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument- Bromage H., Tempst P, Sabatini DM (2003). GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11: 895-904.
83. Kim J., Kundu M, Viollet B, Guan KL (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13: 132-141.
84. Kim K.W., Hwang M, Moretti L, Jaboin JJ, Cha YI, Lu B (2008). Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4: 659-668.
85. Kim M.S., Jeong EG, Ahn CH, Kim SS, Lee SH, Yoo NJ (2008). Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol 39: 1059-1063.
86. Kim S.Y., Oh YL, Kim KM, Jeong EG, Kim MS, Yoo NJ, Lee SH (2008). Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers. Pathology 40: 553-557.
87. Kirisako T., Ichimura Y, Okada H, Kabeya Y, Mizushima N, Yoshimori T., Ohsumi M, Takao T, Noda T, Ohsumi Y (2000). The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol 151: 263-76.
88. Klebig C., Seitz S, Arnold W, Deutschmann N, Pacyna-Gengelbach M, Scherneck S., Petersen I (2005). Characterization of {gamma}- aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer. Cancer Res 65: 394-400.
89. Klionsky DJ (2007). Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8: 931-937.
90. Klionsky D.J., Meijer AJ, Codogno P (2005). Autophagy and p70S6 kinase. Autophagy 1: 59-61.
91. Klionsky D.J., Schulman BA (2014). Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins. Nat Struct Mol Biol 21: 336-345.
92. Knaevelsrud H., Ahlquist T, Merok MA, Nesbakken A, Stenmark H, Lothe R.A., Simonsen A (2010). UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy. Autophagy 6: 863-870.
93. Ko Y.H., Cho YS, Won HS, An HJ, Sun DS, Hong SU, Park JH, Lee MA (2013). Stage-stratified analysis of prognostic significance of Bax-interacting factor-1 expression in resected colorectal cancer. Biomed Research International 2013: 329839.
94. Korkmaz G., le Sage C, Tekirdag KA, Agami R, Gozuacik D (2012). miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy 8: 165-176.
95. Korkmaz G., Tekirdag KA, Ozturk DG, Kosar A, Sezerman OU, Gozuacik D (2013). MIR376A is a regulator of starvationinduced autophagy. PLoS One 8: e82556.
96. Koukourakis M.I., Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC, Harris AL (2010). Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer 103: 1209-1214.
97. Kouroku Y., Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S, Kaufman R.J., Kominami E, Momoi T (2007). ER stress (PERK/ eIF2alpha phosphorylation) mediates the polyglutamineinduced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 14: 230-239.
98. Kraft C, Reggiori F, Peter M (2009). Selective types of autophagy in yeast. Biochim Biophys Acta 1793: 1404-1412.
99. Kuma A., Mizushima N (2010). Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. Semin Cell Dev Biol 21: 683-690.
100. Laddha S.V., Ganesan S, Chan CS, White E (2014). Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol Cancer Res 12: 485-490.
101. Lazova R., Klump V, Pawelek J (2010). Autophagy in cutaneous malignant melanoma. J Cutan Pathol 37: 256-268.
102. Lee I.H., Finkel T (2009). Regulation of autophagy by the p300 acetyltransferase. J Biol Chem 284: 6322-6328.
103. Lee J.W., Jeong EG, Lee SH, Yoo NJ (2007). Somatic mutations of BECN1, an autophagy-related gene, in human cancers. APMIS 115: 750-756.
104. Lee J.W., Jeong EG, Soung YH, Nam SW, Lee JY, Yoo NJ, Lee SH (2006). Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 38: 312-315.
105. Levine B (2007). Cell biology: autophagy and cancer. Nature 446: 745-747.
106. Levine B., Kroemer G (2008). Autophagy in the pathogenesis of disease. Cell 132: 27-42.
107. Li B.X., Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, Zhu XF, Zhang XS (2009). The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 5: 303-306.
108. Li J., Hou N, Faried A, Tsutsumi S, Kuwano H (2010). Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur J Cancer 46: 1900-1909.
109. Li X., Lu Y, Pan T, Fan Z (2010). Roles of autophagy in cetuximabmediated cancer therapy against EGFR. Autophagy 6: 1066- 1077.
110. Li Z., Chen B, Wu Y, Jin F, Xia Y, Liu X (2010). Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer 10: 98.
111. Liang C., Feng P, Ku B, Dotan I, Canaani D, Oh BH, Jung JU (2006). Autophagic and tumour suppressor activity of a novel Beclin1- binding protein UVRAG. Nat Cell Biol 8: 688-699.
112. Liang X.H., Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
113. Lin C.I., Whang EE, Donner DB, Du J, Lorch J, He F, Jiang X, Price BD, Moore FD Jr, Ruan DT (2010). Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer. Mol Cancer Res 8: 1217-1226.
114. Liu C., Xia Y, Jiang W, Liu Y, Yu L (2014). Low expression of GABARAPL1 is associated with a poor outcome for patients with hepatocellular carcinoma. Oncol Rep 31: 2043-2048.
115. Liu J., Lin Y, Yang H, Deng Q, Chen G, He J (2011). The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Tumour Biol 32: 1113-1121.
116. Liu Q., Wang JJ, Pan YC, Meng LF, Zhan X, Zheng QF (2008). Expression of autophagy-related genes Beclin1 and MAPLC3 in non-small cell lung cancer. Ai Zheng 27: 25-29 (article in Chinese with English abstract).
117. Livesey K.M., Tang D, Zeh HJ, Lotze MT (2009). Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 10: 1269-1279.
118. Lock R., Kenific CM, Leidal AM, Salas E, Debnath J (2014). Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov 4: 466-479.
119. Lu Z., Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y., Mills GB et al. (2008). The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 118: 3917-3929.
120. Luo S., Rubinsztein DC (2010). Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ 17: 268-277.
121. Luo S., Xing D, Wei Y, Chen Q (2010). Inhibitive effects of photofrin on cellular autophagy. J Cell Physiol 224: 414-422.
122. Ma Y., Chen B, Xu X, Lin G (2013a). Prospective nested casecontrol study of feature genes related to leukemic evolution of myelodysplastic syndrome. Mol Biol Rep 40: 469-476.
123. Ma Y., Galluzzi L, Zitvogel L, Kroemer G (2013b). Autophagy and cellular immune responses. Immunity 39: 211-227.
124. Maiuri M.C., Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, Tasdemir E., Pierron G, Troulinaki K, Tavernarakis N et al. (2007). Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1. EMBO J 26: 2527-2539.
125. Mammucari C., Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P., Burden SJ, Di Lisi R, Sandri C, Zhao J et al. (2007). FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6: 458-471.
126. Manalo D.J., Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669.
127. Marino G., Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N, Lopez-Otin C. (2007). Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/ autophagin-3. J Biol Chem 282: 18573-18583.
128. Martin A.P., Mitchell C, Rahmani M, Nephew KP, Grant S, Dent P (2009). Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biol Ther 8: 2084-2096.
129. Massey A.C., Zhang C, Cuervo AM (2006). Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 73: 205- 235.
130. Mathew R., Karantza-Wadsworth V, White E (2009a). Assessing metabolic stress and autophagy status in epithelial tumors. Methods Enzymol 453: 53-81.
131. Mathew R., Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C et al. (2009b). Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075.
132. Mathew R., Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin S, White E (2007). Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21: 1367-1381.
133. Matsunaga K., Morita E, Saitoh T, Akira S, Ktistakis NT, Izumi T, Noda T., Yoshimori T (2010). Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L. J Cell Biol 190: 511-521.
134. Meijer A.J., Codogno P (2004). Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 36: 2445-2462.
135. Meley D., Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MT, Codogno P, Meijer AJ (2006). AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 281: 34870-34879.
136. Miao Y., Zhang Y, Chen Y, Chen L, Wang F (2010). GABARAP is overexpressed in colorectal carcinoma and correlates with shortened patient survival. Hepatogastroenterology 57: 257- 261.
137. Mijaljica D., Devenish RJ (2011). A conference report from "Down Under": talking autophagy at OzBio2010. Autophagy 7: 252- 254.
138. Miracco C., Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, Monciatti I., Mannucci S, Biagioli M, Toscano M et al. (2010). Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 41: 503-512.
139. Miracco C., Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, Mannucci S, De Nisi MC, Toscano M, Malagnino V et al. (2007). Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 30: 429-436.
140. Mizushima N., Levine B (2010). Autophagy in mammalian development and differentiation. Nat Cell Biol 12: 823-830.
141. Mizushima N., Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y, Yoshimori T (2001). Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 152: 657-668.
142. Mizushima N., Yoshimori T, Ohsumi Y (2011). The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27: 107-132.
143. Mondesire W.H., Jian W, Zhang H, Ensor J, Hung MC, Mills GB, Meric-Bernstam F. (2004). Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells. Clin Cancer Res 10: 7031- 7042.
144. Morselli E., Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G (2009). Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 1793: 1524-1532.
145. Munafo D.B., Colombo MI (2002). Induction of autophagy causes dramatic changes in the subcellular distribution of GFP-Rab24. Traffic 3: 472-482.
146. Munz C (2009). Enhancing immunity through autophagy. Annu Rev Immunol 27: 423-449.
147. Murrow L., Debnath J (2013). Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu Rev Pathol 8: 105-137.
148. Nakatogawa H., Suzuki K, Kamada Y, Ohsumi Y (2009). Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 10: 458-467.
149. Nicoli E.R., Dumitrescu T, Uscatu CD, Popescu FD, Streata I, Serban Sosoi S., Ivanov P, Dumitrescu A, Barbalan A, Lungulescu D et al. (2014). Determination of autophagy gene ATG16L1 polymorphism in human colorectal cancer. Rom J Morphol Embryol 55: 57-62.
150. Nicotra G., Mercalli F, Peracchio C, Castino R, Follo C, Valente G, Isidoro C (2010). Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol 23: 937-950.
151. Nomura H., Uzawa K, Yamano Y, Fushimi K, Ishigami T, Kouzu Y, Koike H, Siiba M, Bukawa H, Yokoe H et al. (2009). Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis. Hum Pathol 40: 83-91.
152. Oral O., Oz-Arslan D, Itah Z, Naghavi A, Deveci R, Karacali S, Gozuacik D (2012). Cleavage of Atg3 protein by caspase-8 regulates autophagy during receptor-activated cell death. Apoptosis 17: 810-820.
153. Othman E.Q., Kaur G, Mutee AF, Muhammad TS, Tan ML (2009). Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues. J Clin Lab Anal 23: 249-258.
154. Otomo C., Metlagel Z, Takaesu G, Otomo T (2013). Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol 20: 59-66.
155. Paglin S., Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J (2001). A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61: 439-444.
156. Pandya K.J., Dahlberg S, Hidalgo M, Cohen RB, Lee MW, Schiller JH, Johnson DH (2007). A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensivestage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500). J Thorac Oncol 2: 1036-1041.
157. Pattingre S., Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M., Schneider MD, Levine B (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927- 939.
158. Plantinga T.S., van de Vosse E, Huijbers A, Netea MG, Joosten LA, Smit J.W., Netea-Maier RT (2014). Role of genetic variants of autophagy genes in susceptibility for non-medullary thyroid cancer and patients outcome. PLoS One 9: e94086.
159. Qin Z., Xue J, He Y, Ma H, Jin G, Chen J, Hu Z, Liu X, Shen H (2013). Potentially functional polymorphisms in ATG10 are associated with risk of breast cancer in a Chinese population. Gene 527: 491-495.
160. Qu X., Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y et al. (2003). Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820.
161. Rabinowitz J.D., White E (2010). Autophagy and metabolism. Science 330: 1344-1348.
162. Rao S., Yang H, Penninger JM, Kroemer G (2014). Autophagy in nonsmall cell lung carcinogenesis: a positive regulator of antitumor immunosurveillance. Autophagy 10: 529-531.
163. Ravikumar B., Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F., Easton DF, Duden R, O'Kane CJ et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36: 585-595.
164. Reef S., Zalckvar E, Shifman O, Bialik S, Sabanay H, Oren M, Kimchi A (2006). A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol Cell 22: 463-475.
165. Roberts S.S., Mendonca-Torres MC, Jensen K, Francis GL, Vasko V (2009). GABA receptor expression in benign and malignant thyroid tumors. Pathol Oncol Res 15: 645-650.
166. Roberts S.S., Mori M, Pattee P, Lapidus J, Mathews R, O'Malley JP, Hsieh YC, Turner MA, Wang Z, Tian Q et al. (2004). GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. J Clin Oncol 22: 4127-4134.
167. Rothe K., Lin H, Lin KB, Leung A, Wang HM, Malekesmaeili M, Brinkman R.R., Forrest DL, Gorski SM, Jiang X (2014). The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells. Blood 123: 3622-3634.
168. Rouschop K.M., van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW et al. (2010). The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 120: 127-141.
169. Rubinstein A.D., Kimchi A (2012). Life in the balance - a mechanistic view of the crosstalk between autophagy and apoptosis. J Cell Sci 125: 5259-5268.
170. Russell S.E., Hickey GI, Lowry WS, White P, Atkinson RJ (1990). Allele loss from chromosome 17 in ovarian cancer. Oncogene 5: 1581-1583.
171. Saito H., Inazawa J, Saito S, Kasumi F, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y (1993). Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 53: 3382-3385.
172. Salih D.A., Brunet A (2008). FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 20: 126-136.
173. Sato K., Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y, Ueno T, Ochiai A., Esumi H (2007). Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 67: 9677-9684.
174. Satoo K., Noda NN, Kumeta H, Fujioka Y, Mizushima N, Ohsumi Y, Inagaki F (2009). The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagy. EMBO J 28: 1341-1350.
175. Scherz-Shouval R., Shvets E, Fass E, Shorer H, Gil L, Elazar Z (2007). Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749- 1760.
176. Schlottmann S., Buback F, Stahl B, Meierhenrich R, Walter P, Georgieff M., Senftleben U (2008). Prolonged classical NF-κB activation prevents autophagy upon E. coli stimulation in vitro: a potential resolving mechanism of inflammation. Mediators Inflamm 2008: 725854.
177. Schneider J.L., Cuervo AM (2014). Autophagy and human disease: emerging themes. Curr Opin Genet Dev 26C: 16-23.
178. Shackelford D.B., Shaw RJ (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563-575.
179. Shaid S., Brandts CH, Serve H, Dikic I (2013). Ubiquitination and selective autophagy. Cell Death Differ 20: 21-30.
180. Shani G., Marash L, Gozuacik D, Bialik S, Teitelbaum L, Shohat G, Kimchi A (2004). Death-associated protein kinase phosphorylates ZIP kinase, forming a unique kinase hierarchy to activate its cell death functions. Mol Cell Biol 24: 8611-8626.
181. Shen Y., Li DD, Wang LL, Deng R, Zhu XF (2008). Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 4: 1067-1068.
182. Shi Y., Gera J, Hu L, Hsu JH, Bookstein R, Li W, Lichtenstein A (2002). Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779. Cancer Res 62: 5027-5034.
183. Shingu T., Fujiwara K, Bogler O, Akiyama Y, Moritake K, Shinojima N, Tamada Y, Yokoyama T, Kondo S (2009). Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int J Cancer 124: 1060-1071.
184. Sivridis E., Koukourakis MI, Mendrinos SE, Karpouzis A, Fiska A, Kouskoukis C., Giatromanolaki A (2011). Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res 21: 188-195.
185. Steelman L.S., Navolanic PM, Sokolosky ML, Taylor JR, Lehmann BD, Chappell WH, Abrams SL, Wong EW, Stadelman KM, Terrian DM et al. (2008). Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene 27: 4086-4095.
186. Strohecker A.M., Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, McMahon M, White E (2013). Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov 3: 1272-1285.
187. Su M., Mei Y, Sinha S (2013). Role of the crosstalk between autophagy and apoptosis in cancer. J Oncol 2013: 102735.
188. Sun Q., Fan W, Chen K, Ding X, Chen S, Zhong Q (2008). Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. P Natl Acad Sci USA 105: 19211-19216.
189. Takahashi Y., Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y, Liang C., Jung JU, Cheng JQ, Mule JJ et al. (2007). Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 9: 1142-1151.
190. Takahashi Y., Hori T, Cooper TK, Liao J, Desai N, Serfass JM, Young MM, Park S, Izu Y, Wang HG (2013). Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy. Blood 121: 1622-1632.
191. Takamura A., Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y., Hino O, Tanaka K, Mizushima N (2011). Autophagydeficient mice develop multiple liver tumors. Genes Dev 25: 795-800.
192. Tang J., Deng R, Luo RZ, Shen GP, Cai MY, Du ZM, Jiang S, Yang MT, Fu J.H., Zhu XF (2012). Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients. Breast Cancer Res Treat 134: 549-560.
193. Tangir J., Muto MG, Berkowitz RS, Welch WR, Bell DA, Mok SC (1996). A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene 12: 735- 740.
194. Tasdemir E., Chiara Maiuri M, Morselli E, Criollo A, D'Amelio M, Djavaheri-Mergny M., Cecconi F, Tavernarakis N, Kroemer G (2008). A dual role of p53 in the control of autophagy. Autophagy 4: 810-814.
195. Tekirdag K.A., Korkmaz G, Ozturk DG, Agami R, Gozuacik D (2013). MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5. Autophagy 9: 374-385.
196. Tekirdag K.A., Ozturk DG, Gozuacik D (2014). Regulation of autophagy by miRNAs. In: Hayat M, editor. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, and Infection. Amsterdam, the Netherlands: Elsevier Academic Press, pp. 1-35.
197. Uttenweiler A., Schwarz H, Mayer A (2005). Microautophagic vacuole invagination requires calmodulin in a Ca2+-independent function. J Biol Chem 280: 33289-33297.
198. van der Vaart A, Mari M, Reggiori F (2008). A picky eater: exploring the mechanisms of selective autophagy in human pathologies. Traffic 9: 281-289.
199. Viry E., Paggetti J, Baginska J, Mgrditchian T, Berchem G, Moussay E, Janji B (2014). Autophagy: an adaptive metabolic response to stress shaping the antitumor immunity. Biochem Pharmacol (in press).
200. Vousden KH (2009). Functions of p53 in metabolism and invasion. Biochem Soc Trans 37: 511-517.
201. Wang R.C., Wei Y, An Z, Zou Z, Xiao G, Bhagat G, White M, Reichelt J, Levine B (2012). Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338: 956-959.
202. Wang Z.H., Peng ZL, Duan ZL, Liu H (2006). Expression and clinical significance of autophagy gene Beclin 1 in cervical squamous cell carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 37: 860- 863 (article in Chinese with English abstract).
203. Wei Y., Pattingre S, Sinha S, Bassik M, Levine B (2008). JNK1- mediated phosphorylation of Bcl-2 regulates starvationinduced autophagy. Mol Cell 30: 678-688.
204. White E (2013). Exploiting the bad eating habits of Ras-driven cancers. Genes Dev 27: 2065-2071.
205. White E., Karp C, Strohecker AM, Guo Y, Mathew R (2010). Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 22: 212-217.
206. Wong E., Cuervo AM (2010). Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb Perspect Biol 2: a006734.
207. Wu H., Yang JM, Jin S, Zhang H, Hait WN (2006). Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res 66: 3015-3023.
208. Wu Z., Chang PC, Yang JC, Chu CY, Wang LY, Chen NT, Ma AH, Desai S.J., Lo SH, Evans CP et al. (2010). Autophagy blockade sensitizes prostate cancer cells towards Src family kinase inhibitors. Genes Cancer 1: 40-49.
209. Xia H.G., Zhang L, Chen G, Zhang T, Liu J, Jin M, Ma X, Ma D, Yuan J (2010). Control of basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy 6: 61-66.
210. Xu H., Yu H, Zhang X, Shen X, Zhang K, Sheng H, Dai S, Gao H (2013). UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma. Int J Clin Exp Pathol 6: 711-717.
211. Yang S., Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G et al. (2011). Pancreatic cancers require autophagy for tumor growth. Genes Dev 25: 717-729.
212. Yoshioka A., Miyata H, Doki Y, Yamasaki M, Sohma I, Gotoh K, Takiguchi S., Fujiwara Y, Uchiyama Y, Monden M (2008). LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int J Oncol 33: 461-468.
213. Young A.R., Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, Tavare S., Arakawa S, Shimizu S, Watt FM (2009). Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798-803.
214. Yousefi S., Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T, Simon HU (2006). Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8: 1124- 1132.
215. Yu K., Shi C, Toral-Barza L, Lucas J, Shor B, Kim JE, Zhang WG, Mahoney R., Gaydos C, Tardio L et al. (2010). Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Res 70: 621-631.
216. Yue Z., Jin S, Yang C, Levine AJ, Heintz N (2003). Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. P Natl Acad Sci USA 100: 15077-15082.
217. Zalckvar E., Berissi H, Eisenstein M, Kimchi A (2009). Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy 5: 720-722.
218. Zhang Z., Shao Z, Xiong L, Che B, Deng C, Xu W (2009). Expression of Beclin1 in osteosarcoma and the effects of down-regulation of autophagy on the chemotherapeutic sensitivity. J Huazhong Univ Sci Technolog Med Sci 29: 737-740.
219. Zhao X., Gao S, Ren H, Huang H, Ji W, Hao J (2014). Inhibition of autophagy strengthens celastrol-induced apoptosis in human pancreatic cancer in vitro and in vivo models. Curr Mol Med 14: 555-563.
220. Zhong Y., Wang QJ, Yue Z (2009). Atg14L and Rubicon: yin and yang of Beclin 1-mediated autophagy control. Autophagy 5: 890-891.
221. Zhu H., Wu H, Liu X, Li B, Chen Y, Ren X, Liu CG, Yang JM (2009). Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 5: 816-823.